Φορτώνει......
In vivo administration of recombinant BTNL2-Fc fusion protein ameliorates graft-versus-host disease in mice
Although hematopoietic stem cell transplantation (HSCT) has been widely used in the treatment of many diseases, graft-versus-host disease (GVHD) remains a major complication after allogeneic HSCT. Butyrophilin-like 2 (BTNL2) protein has been reported to have the ability to inhibit T cell proliferati...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cell Immunol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6368466/ https://ncbi.nlm.nih.gov/pubmed/30389093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2018.10.008 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|